Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2009 1
2010 2
2011 1
2013 1
2014 1
2015 4
2016 4
2018 4
2019 1
2020 3
2021 2
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
The Relevance of Monoclonal Antibodies in the Treatment of COVID-19.
Torrente-López A, Hermosilla J, Navas N, Cuadros-Rodríguez L, Cabeza J, Salmerón-García A. Torrente-López A, et al. Among authors: salmeron garcia a. Vaccines (Basel). 2021 May 26;9(6):557. doi: 10.3390/vaccines9060557. Vaccines (Basel). 2021. PMID: 34073559 Free PMC article. Review.
Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing.
Pérez-Robles R, Salmerón-García A, Hermosilla J, Torrente-López A, Clemente-Bautista S, Jiménez-Lozano I, Cabañas-Poy MJ, Cabeza J, Navas N. Pérez-Robles R, et al. Among authors: salmeron garcia a. Eur J Pharm Biopharm. 2023 Mar;184:103-115. doi: 10.1016/j.ejpb.2023.01.001. Epub 2023 Jan 18. Eur J Pharm Biopharm. 2023. PMID: 36669672 Free article.
Tracking the physicochemical stability of teduglutide (Revestive®) clinical solutions over time in different storage containers.
Pérez-Robles R, Hermosilla J, Navas N, Clemente-Bautista S, Jiménez-Lozano I, Cabañas-Poy MJ, Ruiz-Travé J, Hernández-García MA, Cabeza J, Salmerón-García A. Pérez-Robles R, et al. Among authors: salmeron garcia a. J Pharm Biomed Anal. 2022 Nov 30;221:115064. doi: 10.1016/j.jpba.2022.115064. Epub 2022 Sep 17. J Pharm Biomed Anal. 2022. PMID: 36152491 Free article.
Medication reconciliation at admission to surgical departments.
González-García L, Salmerón-García A, García-Lirola M, Moya-Roldán S, Belda-Rustarazo S, Cabeza-Barrera J. González-García L, et al. Among authors: salmeron garcia a. J Eval Clin Pract. 2016 Feb;22(1):20-25. doi: 10.1111/jep.12403. Epub 2015 Jun 17. J Eval Clin Pract. 2016. PMID: 26083630
Topical endotracheal mitomycin C as a complementary treatment for endoscopic treatment of recurrent laryngotracheal stenosis.
Cortés de Miguel S, Cabeza Barrera J, Gallardo Medina M, Cassini Gómez de Cádiz LF, Salmerón-García A, Rodríguez Lucas F. Cortés de Miguel S, et al. Among authors: salmeron garcia a. Farm Hosp. 2011 Jan-Feb;35(1):32-5. doi: 10.1016/j.farma.2010.04.002. Epub 2010 Dec 16. Farm Hosp. 2011. PMID: 20663704 Free article. Review. English, Spanish.
Detection of adverse drug reactions through the minimum basic data set.
Salmerón-García A, Cabeza Barrera J, Vergara Pavón MJ, Román Márquez E, Cortés de Miguel S, Vallejo-Rodríguez I, Raya García S, Casado Fernández E. Salmerón-García A, et al. Pharm World Sci. 2010 Jun;32(3):322-8. doi: 10.1007/s11096-010-9372-2. Epub 2010 Mar 6. Pharm World Sci. 2010. PMID: 20213432
30 results